Molecular analysis of the hydroxymethylbilane synthase (HMBS) gene in Italian patients with acute intermittent porphyria: Report of four novel mutations [PDF]
Acute intermittent porphyria (AIP) is an autosomal disorder caused by molecular abnormalities in the hydroxymethylbilane synthase (HMBS) gene coding for the third enzyme in the heme biosynthetic pathway. So far, more than 160 different mutations responsible for AIP have been identified in this gene.
Maria Domenica Cappellini +2 more
exaly +7 more sources
Functional and structural analysis of a novel splice site HMBS variant in a Chinese AIP patient [PDF]
Background: Acute intermittent porphyria (AIP) is a rare metabolic disorder that results from mutations in the gene encoding hydroxymethylbilane synthase (HMBS), an enzyme involved in heme biosynthesis.
Xiaoqing Wang +8 more
doaj +2 more sources
Real-time PCR of the mammalian hydroxymethylbilane synthase (HMBS) gene for analysis of flea (
Background Precise data on quantitative kinetics of blood feeding of fleas, particularly immediately after contact with the host, are essential for understanding dynamics of flea-borne disease transmission and for evaluating flea control strategies ...
Wang Chengming +6 more
doaj +5 more sources
HMBS is the most suitable reference gene for RT‑qPCR in human HCC tissues and blood samples
Reverse transcription-quantitative (RT-q) PCR is the most feasible and useful technique for identifying and evaluating cancer biomarkers; however, the method requires suitable reference genes for gene expression analysis. The aim of the present study was to identify the most suitable reference gene for the normalization of relative gene expression in ...
Ahn, Hye Ri +9 more
openaire +4 more sources
Adenosine metabolism as an endogenous protective mechanism in response to upstream ischemic injury [PDF]
BackgroundFollowing ischemic stroke (IS), endogenous protective mechanisms are activated to mitigate brain injury. Adenosine (ADO), a key endogenous immunomodulator, is implicated in this response, yet the precise regulatory pathways linking upstream ...
Liguo Zhang +6 more
doaj +2 more sources
Pseudoexon Activation in the HMBS Gene as a Cause of the Nonerythroid Form of Acute Intermittent Porphyria [PDF]
To the Editor: Acute intermittent porphyria (AIP)1 (MIM 176000) is a low-penetrance, autosomal dominant disorder caused by decreased activity of the third enzyme in the pathway of heme biosynthesis, hydroxymethylbilane synthase (HMBS). Partial deficiency of HMBS can lead to episodic life-threatening neurovisceral attacks of acute porphyria, which are ...
Jonathan M Rhodes +2 more
exaly +3 more sources
Reference gene selection for the shell gland of laying hens in response to time-points of eggshell formation and nicarbazin. [PDF]
Ten reference genes were investigated for normalization of gene expression data in the shell gland of laying hens. Analyses performed with geNorm revealed that hypoxanthine phosphoribosyltransferase 1 (HPRT1) and hydroxymethylbilane synthase (HMBS) were ...
Sami Samiullah +2 more
doaj +2 more sources
A novel <i>HMBS</i> gene mutation in acute intermittent porphyria: a case report of abdominal pain, seizures, and reversible neuroimaging findings. [PDF]
BackgroundAcute intermittent porphyria (AIP) is a rare metabolic disorder resulting from defects in the heme biosynthesis pathway, often presenting with non-specific symptoms such as abdominal pain, seizures, and neuropsychiatric disturbances. Diagnosis is challenging due to the overlap of symptoms with other conditions, and early recognition is ...
Dong W +7 more
europepmc +4 more sources
Acute intermittent porphyria (AIP, OMIM 176000) is an autosomal dominant metabolic disease caused by mutations in the gene encoding hydroxymethylbilane synthase (HMBS; EC 4.3.1.8; formely named porphobilinogen deaminase, PBGD), mapped to chromosome 11q23.
Georgina Severo Ribeiro +8 more
doaj +2 more sources
Limited benefit of liver transplantation in a boy with biallelic severe deficiency of hydroxymethylbilane synthase and review of prior reported cases [PDF]
Introduction: A male infant presented at three months of age with generalized ataxia, hypotonia, aspiration of liquids and recurrent generalized seizures. He was treated with levetiracetam and phenobarbital.
Manuela Araque +5 more
doaj +2 more sources

